- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07025746
- Original Trial
Acute Effects of Gastrocnemius Myofascial Release on Cervical Flexion and Extension Range of Motion in Healthy Adults
Acute Effects of Gastrocnemius Myofascial Release on Cervical Flexion and Extension Range of Motion in Healthy Adults: A Randomized Controlled Trial
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Porto, Portugal, 4249-004
- Escola Superior de Saúde Fernando Pessoa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy participants of both sexes aged 18-40 years.
Exclusion Criteria:
- Deformities in the lower quadrant region of the body;
- Complaints in this region in the last 6 months;
- Surgical procedures or musculoskeletal, cardiac, renal, metabolic, neurological and or oncological pathologies;
- Limb length discrepancy greater than 1.5 cm;
- Pregnant women;
- Ingestion of non-steroidal anti-inflammatory drugs or consumption of any type of narcotic drugs and participants who have drunk alcohol in the last 12 hours.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The participants will remain at rest in a chair for 4 minutes.
|
|
|
Active Comparator: Intervention group
A myofascial release technique will be performed using a foam roller (Blackroll Standard, 30 x 15 cm) on the dominant lower limb. For the Intervention Group (IG), the technique will be applied to the gastrocnemius muscles. In this group, participants will adopt a semi-seated position on a mat, supported by their arms while keeping the body well aligned. The movement will be performed in the direction of the muscle fibers (cephalocaudal), ensuring the accuracy of the technique. The foam roller will be in contact with the targeted muscle, and the participant will apply pressure until experiencing slight discomfort. In this way, a self-massage will be performed following the direction of the muscle fibers. |
The foam roller will be in contact with the muscle being tested and the patient will exert a load until they feel a slight pain.
In this way, the patient performs a self-massage in the direction of the muscle fibers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of active cervical range of motion in flexion and extension.
Time Frame: Change from Baseline (M0) to Immediately after intervention or control (M1)
|
Data will be collected at two time points: baseline assessment (M0) and after the intervention/control (M1). Participants will be instructed to sit with their spine straight and supported against the backrest of the chair, with ankles, knees, and hips positioned at 90 degrees. Arms will remain crossed over the chest to prevent compensatory thoracic movements. Before the test begins, each participant will be asked to actively perform the flexion and extension movements to the limit of their range of motion, aiming to reduce stiffness and promote familiarization with the assessment protocol. Measurements will be taken three times for each movement (active flexion and extension), with 30-second rest intervals between each measurement. The average of the three values will be calculated and recorded as the final value. |
Change from Baseline (M0) to Immediately after intervention or control (M1)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ESS/LFST-706/25-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.